In Pain due to muscle spasm Flexabenz Plus Tablet SR treats pain due to muscle spasm by relaxing stiff muscles. It also reduces swelling in the muscles. Altogether, it helps in easy movement and reduces discomfort. Once you see some improvement, you can start doing therapy exercises (such as walking or breathing exercises) that will help you get your strength back more quickly. It is advisable to continue taking Flexabenz Plus Tablet SR until your doctor advises you to stop.
It is unsafe to consume alcohol with Flexabenz Plus Tablet SR.
Flexabenz Plus Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Flexabenz Plus Tablet SR during breastfeeding is not available. Please consult your doctor.
Flexabenz Plus Tablet SR may cause side effects which could affect your ability to drive.
Flexabenz Plus Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Flexabenz Plus Tablet SR may be needed. Please consult your doctor. Use of Flexabenz Plus Tablet SR is not recommended in patients with severe kidney disease.
Flexabenz Plus Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Flexabenz Plus Tablet SR may be needed. Please consult your doctor. Use of Flexabenz Plus Tablet SR is not recommended in patients with severe liver disease. Regular monitoring of liver function tests is advisable while the patient is taking this medicine.
If you miss a dose of Flexabenz Plus Tablet SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
| QTY | Stock Status | Brand Name | Generic Name | Strength | Form | Size | MRP | Discount | Net Cost | MFR | Type | Add Cart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No substitutes found. | ||||||||||||